AAAAAA

   
Results: 1-8 |
Results: 8
INHIBITION OF HUMAN HEPATIC CYTOCHROME P4502E1 BY AZOLE ANTIFUNGALS, CNS-ACTIVE DRUGS AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS
Authors: TASSANEEYAKUL W BIRKETT DL MINERS JO
Citation: W. Tassaneeyakul et al., INHIBITION OF HUMAN HEPATIC CYTOCHROME P4502E1 BY AZOLE ANTIFUNGALS, CNS-ACTIVE DRUGS AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS, Xenobiotica, 28(3), 1998, pp. 293-301
LIMITED VALUE OF THE URINARY PHENYTOIN METABOLIC RATIO FOR THE ASSESSMENT OF CYTOCHROME P4502C9 ACTIVITY IN-VIVO
Authors: TASSANEEYAKUL W BIRKETT DJ PASS MC MINERS JO
Citation: W. Tassaneeyakul et al., LIMITED VALUE OF THE URINARY PHENYTOIN METABOLIC RATIO FOR THE ASSESSMENT OF CYTOCHROME P4502C9 ACTIVITY IN-VIVO, British journal of clinical pharmacology, 42(6), 1996, pp. 774-778
HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE
Authors: TASSANEEYAKUL W BIRKETT DJ EDWARDS JW VERONESE ME TASSANEEYAKUL W TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 101-108
DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2
Authors: TASSANEEYAKUL W BIRKETT DJ VERONESE ME MCMANUS ME TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2, Pharmacogenetics, 4(5), 1994, pp. 281-284
CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS
Authors: TASSANEEYAKUL W BIRKETT DJ MCMANUS ME TASSANEEYAKUL W VERONESE ME ANDERSSON T TUKEY RH MINERS JO
Citation: W. Tassaneeyakul et al., CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS, Biochemical pharmacology, 47(10), 1994, pp. 1767-1776
IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM
Authors: ANDERSSON T MINERS JO VERONESE ME TASSANEEYAKUL W TASSANEEYAKUL W MEYER UA BIRKETT DJ
Citation: T. Andersson et al., IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM, British journal of clinical pharmacology, 36(6), 1993, pp. 521-530
SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2
Authors: TASSANEEYAKUL W BIRKETT DJ VERONESE ME MCMANUS ME TUKEY RH QUATTROCHI LC GELBOIN HV MINERS JO
Citation: W. Tassaneeyakul et al., SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 401-407
VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES
Authors: TASSANEEYAKUL W VERONESE ME BIRKETT DJ GONZALEZ FJ MINERS JO
Citation: W. Tassaneeyakul et al., VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES, Biochemical pharmacology, 46(11), 1993, pp. 1975-1981
Risultati: 1-8 |